Ora Experts Share Knowledge In Retinal Imaging And Dry Eye Therapies At GTCbi bi2692347 During the recent GTCbio Conference Boston two leading experts, Dr. Avner Ingerman, MD, MSc and George Ousler, both from Ora, Inc., shared industry expertise on retinal imaging and dry eye therapies high-level industry executives, clinical researchers, and government officials. Dr. Avner Ingerman, MD, MSc, Senior Vice President, General Manager, Retina, at Ora, Inc..

Ora Experts Share Knowledge Retinal Imaging and Dry Eye Therapies at GTCbi bi2692347 ANDOVER, MA--(Marketwire - June 24, 2010) - During the recent GTCbio Conference Boston two leading experts, Dr. Avner Ingerman, MD, MSc and George Ousler, both from Ora, Inc., shared industry expertise on retinal imaging and dry eye therapies high-level industry executives, clinical researchers, and government officials

Vision alert for fathersera bi2692347 IF we think that our fathers wear glasses only because of regular vision problems that come age, we might have to take a closer look. Blurry vision can lead to cataract, an eye problem posing complications that could lead to blindness

Microplasmin study shows promising results for two serious eye conditions bi2692347 A Phase III trial of a drug used for the treatment of vitreomacular adhesion (VMA) and macular hole (MH) revealed key findings for patients diagnosed these severe conditions can lead to significant vision impairment

Microplasmin Study Shows Promising Results For Two Serious Eye Conditions bi2692347 A Phase III trial of a drug used for the treatment of vitreomacular adhesion (VMA) and macular hole (MH) revealed key findings for patients diagnosed these severe conditions can lead to significant vision impairment. Dr. Matthew Benz, retinal surgeon at The Methodist Hospital Houston, presented the data of the microplasmin trial (TG-MV-006) on behalf of ThromboGenics NV, at the ..

ThromboGenics Presents New Exciting Microplasmin Phase III Data at the World bi2692347 LEUVEN, Belgium, June 7, 2010 /PRNewswire-FirstCall/ -- - Data Presented Show Microplasmin Cures Approximately 50% of Patients With Macular Hole ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial microplasmin (TG-MV-006 ..

Ingredient red wine may prevent some blinding diseases bi2692347 Resveratrol -- found red wine, grapes, blueberries, peanuts and other plants -- stops out-of-control blood vessel growth the eye, according to vision researchers. The discovery has implications for preserving vision blinding eye diseases such as diabetic retinopathy and age-related macular degeneration, the leading cause of blindness Americans over 50

Red Wine Ingredient May Prevent Some Blinding Diseases bi2692347 Resveratrol inhibits formation of damaging blood vessels mouse retina Resveratrol found red wine, grapes, blueberries, peanuts and other plants stops out-of-control blood vessel growth the eye, according to vision researchers at Washington University School of Medicine St

First clinical trial results of XOMA 052 patients uveitis of Behcet's bi2692347 XOMA Ltd., a leader the discovery and development of therapeutic antibodies, announced positive results from an open-label pilot study of XOMA 052 patients uveitis of Behcet's disease who were suffering from vision-threatening exacerbations despite maximal doses of immunosuppressive medicines

Positive Clinical Findings Presented on XOMA 052 Debilitating Eye Disease bi2692347 ROME -- XOMA Ltd. , a leader the discovery and development of therapeutic antibodies, announced positive results from an open-label pilot study of XOMA 052 patients uveitis of Behcet's disease who were suffering from vision-threatening exacerbations despite maximal doses of immunosuppressive medicines

Longer Antiviral Therapy Reduces Lung Transplant Complications bi2692347 Title: Longer Antiviral Therapy Reduces Lung Transplant Complications Category: Health News Created: 6/14/2010 4:10:00 PM Last Editorial Review: 6/15/2010..

Vikings receiver Rice to miss half season, or more, following hip surgery - P bi2692347 Washington PostVikings receiver Rice to miss half season, or more, following hip Philadelphia Daily NewsFavre and the Minnesota Vikings play the first half of the season, or more, Pro Bowl receiver Sidney Rice, who had hip week. Rice may miss eight games after , adds tCBSSports.comVikings WR Sidney Rice has hip , may miss much or all of seasonUSA TodayRice has hip , out half the seasonYahoo! SportsBleacher Report -Fort Wayne Journal Gazette -Washington Post (blog)all 632 news articles »..

Cameron's season-ending surgery Friday - MLB.com bi2692347 Cameron's season-ending FridayMLB.comOn the disabled list twice year a lower abdominal strain, Cameron have season-ending Friday, be Mike Cameron's set for FridayESPNCameron to have ; Red Sox activate C CashMiamiHerald.comMike Cameron to have NECNRotoworld.com -Boston Heraldall 60 news articles »..

Back Surgery Options - Home